申请人:Miyaji Katsuaki
公开号:US20090131659A1
公开(公告)日:2009-05-21
The present invention provides compounds useful for prevention, treatment or alleviation of diseases against which activation of the thrombopoietin receptor is effective.
A compound represented by the formula (1):
wherein A, B, R
1
, L
1
, R
2
, L
2
, L
3
, Y, L
4
, R
3
and X are the same as defined in the description, a tautomer, prodrug or pharmaceutically acceptable salt of the compound or a solvate thereof.
本发明提供了化合物,用于预防、治疗或缓解激活血小板生成素受体对其有效的疾病。其中一种化合物的表示式为(1):其中A、B、R1、L1、R2、L2、L3、Y、L4、R3和X的定义与描述中相同,以及该化合物的互变异构体、前药或药物可接受的盐或其溶剂化物。